Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.5M Buy
12,791
+121
+1% +$43.1K 1.46% 11
2025
Q4
$4.15M Buy
12,670
+1
+0% +$317 1.34% 12
2025
Q3
$3.58M Buy
12,669
+1,021
+9% +$296K 1.23% 15
2025
Q2
$3.25M Sell
11,648
-266
-2% -$75.4K 1.26% 13
2025
Q1
$3.71M Buy
11,914
+11
+0.1% +$3.25K 1.63% 9
2024
Q4
$3.1M Buy
+11,903
New +$3.53M 0.86% 15

Other funds holding AMGN

Alteri Wealth's AMGN Position: Q1 2026 in Review

Alteri Wealth increased its Amgen (AMGN) stake by 0.96% in Q1 2026, buying an estimated $43.1K and bringing the position to 12,791 shares worth $4.5M. The position accounts for 1.46% of the portfolio, ranked #11.

Alteri Wealth first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Alteri Wealth held 12,791 shares of Amgen worth $4.5M as of Q1 2026.
  • Alteri Wealth bought 121 Amgen shares in Q1 2026, an estimated $43.1K.
  • Amgen made up 1.46% of Alteri Wealth's portfolio in Q1 2026, its #11 holding.
  • Alteri Wealth first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Alteri Wealth's 13F filing for Q1 2026, filed 6 May 2026.